What does progress in retinal disease care look like up close? Follow along with Hugh Lin, MD MBA , our VP and Head of Ophthalmology, at the American Society of Retina Specialists (ASRS) annual meeting as he shares a quick look at the cutting-edge science driving our work in retinal disease forward. Check out Hugh’s POV from ASRS in the video below! #ASRS2025
About us
About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or patientinfo@gene.com. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.
- Website
-
http://www.gene.com
External link for Genentech
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- South San Francisco, California
- Type
- Privately Held
- Founded
- 1976
- Specialties
- Oncology, Immunology, Disorders of Tissue Growth and Repair, Neuroscience and Infectious Disease, Metabolism, and Ophthalmology
Locations
-
Primary
1 Dna Way
South San Francisco, California 94080, US
-
1000 New Horizons Way
Vacaville, California 95688, US
-
1 Antibody Way
Oceanside, California 92056, US
-
4625 NE Brookwood Pkwy
Hillsboro, Oregon 97124, US
Employees at Genentech
Updates
-
Without treatment, people with wet AMD may experience rapid and sudden symptoms of vision impairment, including dark spots at the center of their vision – like the one shown here. Through ongoing research, we’re committed to helping improve outcomes for people with wet AMD and other retinal diseases. At #ASRS2025, we’re sharing new, long-term Phase III results from our refillable eye implant that underscores our efforts to advance care for this disease: http://spr.ly/6044fklZ8
-
We’re at #ASRS2025 sharing exciting new data on our treatment options for people living with serious, vision-threatening eye conditions, including wet age-related macular degeneration and diabetic macular edema. Explore the latest research insights here: https://lnkd.in/g-t5KTnU
-
Conducting clinical research that is representative of all patients impacted by a disease, including those from understudied communities, helps us ensure our cutting-edge innovations can reach and benefit everyone who needs them. This is why we’re proud to be expanding our Advancing Inclusive Research® Site Alliance in collaboration with the Global Alzheimer's Platform Foundation. Through this dynamic collaboration, we’re bringing clinical studies into underrepresented communities and breaking down barriers to participation so that all eligible patients can benefit from transformative scientific advances in Alzheimer’s disease. Learn more: http://spr.ly/6043fuxCv
-
#LupusNephritis is one of the most serious manifestations of #lupus, often progressing silently and without clear symptoms. It disproportionately affects women of color, and early diagnosis can make a difference in outcomes. At Genentech, we’re dedicated to raising awareness about this complex condition, and we’re investing in research to better understand it and support those impacted by it. Learn how we’re working to improve outcomes for those affected: http://spr.ly/6046funDn
-
We are presenting new data in #Alzheimers at #AAIC. Learn more about the new insights and our ongoing commitment to advancing the science in this disease: https://lnkd.in/g8sdrjsp
-
Join us #InTheLab as scientists Alecia Dent and Louis Joslyn explore how digital twins—virtual simulations of real-world systems—are helping researchers improve clinical trial outcomes and optimize treatment options. Curious how this advanced tech is reshaping drug development? Tune in to our podcast, Two Scientists Walk into a Bar, to find out. http://spr.ly/6045fHf7B
In the Lab: Simulating with Digital Twins
-
The future of medicine is here – and it’s virtual. 🌐 Digital twins are data-powered virtual models that can be used to simulate how patients may respond to treatment, accelerating drug development and enabling more personalized care. Listen in as scientists Iraj Hosseini and Maria Wilson explore how this technology can supplement clinical trials and transform how we understand and treat diseases. http://spr.ly/60494AaVP
-
-
Data-powered virtual models known as digital twins are advancing drug discovery by allowing scientists to explore “what if” scenarios and optimize treatments for patients. Join our development sciences lead, Iraj Hosseini, and podcast co-host, Maria Wilson, in the latest episode of Two Scientists Walk Into a Bar as they explore this transformative technology: http://spr.ly/60494Aa8F
-
-
This year’s San Francisco Pride Parade was a celebration to remember! Our employees once again brought the Genentech spirit to the streets of San Francisco – including atop our beautiful float in celebration of unity, joy and visibility. From bold signs and bright smiles to moments of connection and reflection, the day reminded us just how powerful it is to be seen and supported for who we are. At Genentech, Pride doesn’t stop in June. We aspire to make our workplace inclusive every day of the year. #PrideMonth
-